1. Home
  2. SKY vs TARS Comparison

SKY vs TARS Comparison

Compare SKY & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skyline Champion Corporation

SKY

Skyline Champion Corporation

N/A

Current Price

$88.70

Market Cap

4.3B

ML Signal

N/A

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

N/A

Current Price

$73.75

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SKY
TARS
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SKY
TARS
Price
$88.70
$73.75
Analyst Decision
Buy
Strong Buy
Analyst Count
7
10
Target Price
★ $101.83
$98.89
AVG Volume (30 Days)
558.2K
★ 706.2K
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
7.02
★ 48.21
EPS
★ 0.89
N/A
Revenue
★ $2,663,639,000.00
$451,360,000.00
Revenue This Year
$4.80
$63.49
Revenue Next Year
$7.49
$24.68
P/E Ratio
$95.33
★ N/A
Revenue Growth
7.26
★ 146.71
52 Week Low
$63.87
$53.89
52 Week High
$99.17
$91.53

Technical Indicators

Market Signals
Indicator
SKY
TARS
Relative Strength Index (RSI) 63.73 52.49
Support Level $73.10 $68.56
Resistance Level $89.89 $74.51
Average True Range (ATR) 2.93 3.19
MACD 1.22 0.56
Stochastic Oscillator 92.14 72.22

Price Performance

Historical Comparison
SKY
TARS

About SKY Skyline Champion Corporation

Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several locations across the US. The Company has two reportable segment U.S. Factory-built Housing and Canadian Factory-built Housing. The majority of the revenue is generated from U.S. Factory-built Housing.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: